MICS+aspheric IOL = fewer corneal changes

Article

Microincision cataract surgery (MICS) with implantation of an aspheric intraocular lens (IOL) through a 1.8 mm incision can minimize surgically-induced corneal and ocular aberrations and improve optical performance, according to a French study.

Microincision cataract surgery (MICS) with implantation of an aspheric intraocular lens (IOL) through a 1.8 mm incision can minimize surgically-induced corneal and ocular aberrations and improve optical performance, according to a French study.

Alexandre Denoyer and co-workers from Bretonneau University Hospital, France evaluated the postoperative corneal and ocular aberrations of 20 subjects following MICS with implantation of the aspheric MI60 IOL (Bausch & Lomb) through a 1.8 mm incision in one eye and through a 2.8 mm incision in the other eye.

The researchers found that changes in the corneal topography and aberrations were lower in the MICS group than in the other eye (p<0.05), as were the total ocular wavefront aberrations (p<0.05). Best corrected visual acuity and subjective visual comfort were similar in both groups.

Dr Denoyer concluded that MICS with implantation of an aspheric IOL can help minimize surgically-induced corneal changes.

Recent Videos
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Enrico Borrelli, MD, FEBO, speaks at EURETINA
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
© 2024 MJH Life Sciences

All rights reserved.